- Home
- RIGL vs JAKK Comparison
RIGL vs JAKK Comparison
Compare RIGL & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- JAKK
- Stock Information
- Founded
- RIGL 1996
- JAKK 1995
- Country
- RIGL United States
- JAKK United States
- Employees
- RIGL N/A
- JAKK N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- JAKK Recreational Games/Products/Toys
- Sector
- RIGL Health Care
- JAKK Consumer Discretionary
- Exchange
- RIGL Nasdaq
- JAKK Nasdaq
- Market Cap
- RIGL 366.5M
- JAKK 374.4M
- IPO Year
- RIGL 2000
- JAKK 1996
- Fundamental
- Price
- RIGL $17.17
- JAKK $24.72
- Analyst Decision
- RIGL Buy
- JAKK Strong Buy
- Analyst Count
- RIGL 5
- JAKK 4
- Target Price
- RIGL $36.80
- JAKK $41.75
- AVG Volume (30 Days)
- RIGL 253.6K
- JAKK 116.5K
- Earning Date
- RIGL 03-04-2025
- JAKK 04-23-2025
- Dividend Yield
- RIGL N/A
- JAKK 1.01%
- EPS Growth
- RIGL N/A
- JAKK N/A
- EPS
- RIGL 0.99
- JAKK 3.14
- Revenue
- RIGL $179,278,000.00
- JAKK $691,042,000.00
- Revenue This Year
- RIGL $14.19
- JAKK $2.34
- Revenue Next Year
- RIGL $13.10
- JAKK $4.14
- P/E Ratio
- RIGL $17.17
- JAKK $7.86
- Revenue Growth
- RIGL 54.71
- JAKK N/A
- 52 Week Low
- RIGL $7.48
- JAKK $17.06
- 52 Week High
- RIGL $29.82
- JAKK $35.79
- Technical
- Relative Strength Index (RSI)
- RIGL 34.02
- JAKK 36.66
- Support Level
- RIGL $17.01
- JAKK $23.97
- Resistance Level
- RIGL $19.97
- JAKK $26.49
- Average True Range (ATR)
- RIGL 1.01
- JAKK 0.81
- MACD
- RIGL -0.29
- JAKK 0.10
- Stochastic Oscillator
- RIGL 10.65
- JAKK 15.16
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-brand toy company that designs, produces, markets, and distributes toys and related products, consumables, and related products, electronics and related products, kids' indoor and outdoor furniture, and other consumer products. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others.